Use of canine interferon-.gamma.(IFN-.gamma.) to treat non-atopi

Details Use of canine interferon-.gamma.(IFN-.gamma.) to treat non-atopi Use of canine interferon-.gamma.(IFN-.gamma.) to treat non-atopi

1997-12-31

1999-09-21

Fitzgerald, David L.

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

A61K 3821, C12N 1523

Patent

active

059550694

ABSTRACT:
Methods for treating intractable dermatitis in dogs are described. The methods involve the administration by injection of formulations comprising canine interferon-.gamma. and, optionally, other agents. The canine IFN-.gamma. may be produced in recombinant expression systems such as E. coli or B. mori.

REFERENCES:
Ijzermans et al., Immunobiology, 179, 456-473 (1989).
Himmler et al., J. Interferon Research, 7, 173-183 (1987).
Devos et al., J. Interferon Research, 12, 95-102 (1992).
Hanifin et al., J. Am. Acad. Dermatol., 28, 189-197 (1993).
Reinhold et al., Lancet, 335, 1282 (1990).
Reinhold et al., J. Am Acad. Dermatol., 29, 58-63 (1993).
Nishioka et al., J. Dermatol., 22, 181-185 (1995).
Williams, Br. J. Dermatol., 131, 397-405 (1994).
Sampson et al., J. Allergy Clin. Immunol., 81, 635-645 (1988).
H. Tagami, Jpn. J. Dermatol., 106, 955-964 (1996).
Horiuchi et al., Agic. Biol. Chem., 51, 1573-1580 (1987).
Zucker, K., et al. (1993) J. Interferon Res. 13 (2): 91-97.
Drug Data Report database, Dialog accession No. 00168624, accessed Sep. 21, 1998.

Affiliated with

Also associated with

Rating

Use of canine interferon-.gamma.(IFN-.gamma.) to treat non-atopi does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of canine interferon-.gamma.(IFN-.gamma.) to treat non-atopi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of canine interferon-.gamma.(IFN-.gamma.) to treat non-atopi will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-77486